Skip to main content

Levodopa News

AAN: Tavapadon as Adjunct to Levodopa Ups Daily ON Time in Parkinson Disease

TUESDAY, April 8, 2025 – For patients with Parkinson disease with motor fluctuations, the oral once-daily, selective D1/D5 partial dopamine agonist tavapadon as an adjunct to levodopa increases...

Early Research Points to Possible New Parkinson's Drug

THURSDAY, Dec. 19, 2024 – Parkinson's is a relentless disease for which few treatments, and no real cure, exists. Now, researchers say they are on the trail of a potential new therapy for the...

FDA Approves Inbrija (levodopa inhalation powder) for Intermittent Treatment of OFF Episodes in People with Parkinson’s Disease

ARDSLEY, N.Y.--(BUSINESS WIRE) December 21, 2018 --Acorda Therapeutics, Inc. today announced that the U.S. Food and Drug Administration approved Inbrija™ for intermittent treatment of OFF episodes in ...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Restless Legs Syndrome, Parkinson's Disease, Periodic Limb Movement Disorder

Levodopa patient information at Drugs.com